Bayer is boosting its precision oncology efforts with a molecular database from health tech firm ConcertAI.  | Bayer is ...

Two prominent German investors voiced exasperation over Bayer AG’s recurring struggles, demanding a clearer path out of the ...

ConcertAI has announced an agreement that will allow Bayer to utilise its Translational360 and AI software-as-a-service (SaaS ...

Bayer AG (Leverkusen, Germany) announced the grand opening of its new 70,000 square foot expansion at its Myerstown, ...

The expansion increases packaging and production areas by 70,000 square feet and includes eight packaging lines, according to ...

Bayer BAYRY announced that the FDA has granted full approval to oncology drug, Vitrakvi (larotrectinib), a first-in-class TRK inhibitor. The drug is now fully approved in the United States for ...

The U.S. Food And Drug Administration (FDA) granted full approval to Bayer AG’s (OTC:BAYRY) Vitrakvi (larotrectinib) for adult and pediatric patients with solid tumors that have a neurotrophic ...

Underestimation of low-cost, effective interventions such as aspirin may cause considerable harm. This editorial seeks to review the impact of dosage, timing and adherence to aspirin on its efficacy ...

German drug maker Bayer, which is awaiting regulatory approval for its new drug, elinzanetant, expects it to hit the market soon. This latest non-hormonal treatment is anticipated to be superior ...

“Aspirin is a well-established and a safe medical medication with well-known side effects. The incidence of adverse events was as expected," noted Martling.